The present study also highlights that ENALA treatment can also be repurposed for cervical cancer treatment, as the increased level of TMEM33 was associated with increased tumor cell proliferation and poor prognosis in cervical cancer [27]. The gene discussed is TMEM33; the disease is cervical carcinoma.